{"id":"NCT01470989","sponsor":"Novartis Pharmaceuticals","briefTitle":"Î²-RELIEVED - REsponse in Acute fLare and In prEVEntion of episoDes of Re-flare in Gout - Extension 3 (E3)","officialTitle":"An Open-label Extension Study of CACZ885H2356E2 and CACZ885H2357E2 on the Treatment and Prevention of Gout Flares in Patients With Frequent Flares for Whom NSAIDs and/or Colchicine Are Contraindicated, Not Tolerated or Ineffective","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-11","primaryCompletion":"2013-05","completion":"2013-05","firstPosted":"2011-11-11","resultsPosted":"2021-07-09","lastUpdate":"2021-07-09"},"enrollment":136,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Acute Gouty Arthritis Flares"],"interventions":[{"type":"DRUG","name":"ACZ885","otherNames":["Canakinumab"]},{"type":"DRUG","name":"Triamcinolone acetonide 40 mg","otherNames":["Triamcinolone acetonide"]}],"arms":[{"label":"canakinumab","type":"EXPERIMENTAL"}],"summary":"This was an 18-month, multi-center, open-label, clinical extension study. Patients completing earlier second extension studies (CACZ885H2356E2 and CACZ885H2357E2) continued to be treated in this combined extension 3 study for any new gouty arthritis flare on demand with one subcutaneous (s.c.) injection of canakinumab 150 mg.","primaryOutcome":{"measure":"Number of Incidence Rate (IR) of Adverse Events, Serious Adverse Events and Death Per 100 Patient-years in Participants","timeFrame":"From start of the core studies (CACZ885H2357 [NCT01080131] and CACZ885H2361 [NCT01356602]) up to end of the current study (36 weeks)","effectByArm":[{"arm":"Canakinumab 150 mg","deltaMin":873,"sd":null},{"arm":"Triamcinolone Acetonide 40 mg","deltaMin":451,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":null},"locations":{"siteCount":56,"countries":["United States","Australia","Canada","Estonia","Germany","Latvia","Lithuania","Russia","Ukraine"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":35,"n":225},"commonTop":["Hypertension","Arthralgia","Upper respiratory tract infection","Headache","Back pain"]}}